Home » SOLVAY SEIYAKU, EISAI COLLABORATE ON SA-001
SOLVAY SEIYAKU, EISAI COLLABORATE ON SA-001
Switzerland-based Solvay Pharmaceuticals Marketing & Licensing AG, an affiliate of Solvay Pharmaceuticals (Brussels, Belgium) and Eisai Co. Ltd. concluded a license agreement on Solvay Pharmaceuticals' treatment for pancreatic exocrine insufficiency (SA-001) in Japan.
BioSpectrum (http://www.biospectrumasia.com/content/270706JPN1232.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May